Calmly Rooted Announces Strategic Evolution of “The Calm Collective” Wellness Hub
Clinical cannabis education initiatives are essential for grounding cannabis use in evidence-based frameworks. These initiatives help clinicians understand endocannabinoid biology responsibly. They support safer patient guidance in the evolving cannabis…
Minnesota Officials Recall Tidal Wave THC Vapes for Safety Concerns
Minnesota officials have issued a tidal wave vape recall due to high THC content exceeding legal limits. This recall highlights safety concerns for patients using cannabis vapes with unexpected potency. Clinicians should be aware of these risks and…
Why Ghana’s Academia and Pharma Must Lead Medicinal Cannabis Revolution
Ghana medicinal cannabis research is poised to transform local healthcare by developing evidence-based cannabinoid therapies. Academic and pharmaceutical sectors in Ghana are collaborating to lead clinical trials and product development. This focus on…
7 States That Could Still Legalize Cannabis in 2026
This article explores the 7 states cannabis legalization 2026 landscape and its implications for clinicians. Medical cannabis research programs in these states could expand treatment options. Understanding this evolving policy is essential for…
Ohio Enforces Ban on Intoxicating Hemp-Derived THC Beverages
Ohio has implemented a hemp-derived THC beverages ban affecting intoxicating hemp product availability. Clinicians must counsel patients on this regulatory change and its impact on cannabis access. The hemp-derived THC beverages ban directs patients…
Nebraska Medical Cannabis Commission Awaits Budget and Regulatory Approval
The Nebraska Medical Cannabis Commission budget and regulatory bill are pending legislative approval, crucial for program funding and implementation. This delay affects patient access to medical cannabis in Nebraska. Clinicians should monitor the…
Yale and McGill Expand Cannabis Research Collaboration
The cannabis research collaboration between Yale and McGill expands the evidence base on cannabis efficacy and safety. This partnership addresses critical gaps in clinical research. Clinicians benefit from more rigorous data to inform patient care and…
Cannabis Compound Shows Promise in Fighting Alzheimer’s by Calming Brain Inflammation
Cannabis compounds alzheimers research highlights potential to calm brain inflammation, a key factor in neurodegeneration. Emerging evidence suggests cannabinoids may modulate neuroinflammatory pathways involved in Alzheimer's disease. Clinicians should…
Age-Dependent Psychiatric Risks in Cannabis Use Disorder
Cannabis use disorder psychiatric risks are significantly higher in younger patients, requiring age-stratified clinical assessment. Early intervention is crucial to prevent serious mental illness progression. Clinicians must tailor counseling and…
New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks
Recent studies highlight age-dependent cannabis psychiatric risks, showing younger users face higher vulnerability to mental health issues. This research underscores the importance of age-specific clinical screening. Understanding these risks aids in…